The partnership with Juniper Networks expands Corero’s (LSE: CNS) sales force from just six to hundreds of salespeople.
Share Talk
Social Media Today – If you’re not part of it, you will be left behind
Are today’s financial industry players paying attention to the revolution that is ongoing across the social media landscape today, being played out right in front their eyes?
AIM companies now exempt from maintaining insider lists under the Market Abuse Regulation
MiFID II came into force on 3 January 2018. Among other things, this EU directive establishes the SME Growth Market concept. The European Commission hopes that this new market classification
Thanks for using lse.co.uk
Scott, a Team Member/Director at London South East, with a simple message of thanks to round out 2017 and the
EXCLUSIVE: HemoGenyx are creating blood cancer treatments with US$9 billion market potential
#HEMO are a London-listed, US-based biotech company developing two revolutionary blood cancer treatments. CDX antibodies are intended to remove the need
RNS VIDEO: Reabold Resources #RBD raise £6 million and take stake in Danube Petroleum
Reabold Resources Co-Chief Executives Stephen Williams and Sachin Oza have just successfully raised ‘approximately six million pounds’ to invest in
#PHARMA: Therapix Biosciences are developing ‘medicinal cannabis’ for Tourette’s and sleep apnea
Josh Blacher, CFO at Therapix Biosciences, describes how his company are developing a therapeutic approach to obstructive sleep apnea, and
#PHARMA: French biotech to launch new class of high blood pressure drug
Lionel Segard is Chairman & CEO of Quantum Genomics, a French biotech company launched 11 years ago. Quantam are developing
Shell returns to cash dividends & shifts strategy towards renewables
Global oil giant Royal Dutch Shell has ended its Scrip Dividend Programme and returned to paying cash divis, but how do the fundamentals look? And it makes a major shift
#PHARMA: Want to invest in the new Berkshire Hathaway for Health Care?
Peter Garcia, the CFO at PDL BioPharma explains that in his view, PDL is ‘unique’. Located in Lake Tahoe, Nevada,
#PHARMA: NeuroVive are groundbreaking specialists in mitochondrial treatments
Erik Kinnman, CEO of Swedish biotech company NeuroVive Pharmaceutical, says that his company are at the forefront of research into
#PHARMA: Volition expects to market ‘revolutionary’ colo-rectal cancer blood test Q3 2018
Cameron Reynolds, Volition CEO, told London South East he expects to hit significant clinical test milestones in 2018 and to